Research Excellence Award
Vikrant Verma
Swami Vivekanand Subharti University,India
Vikrant Verma of Swami Vivekanand Subharti University is presented in connection with the Research Excellence Award at the International Soil Scientist Awards. His reported scholarly record comprises 20 documents, 70 citations, and an h-index of 4, with research classified within Biology and Life Sciences. The publication record supplied for this profile reflects interdisciplinary work spanning pharmacology, natural bioactive compounds, radiopharmaceuticals, neurobiology, and cardiovascular research.
Abstract
This academic recognition profile summarizes Vikrant Verma’s documented research activity and selected recent publications. The supplied works address mechanisms of bioactive compounds, Alzheimer’s disease, alkaloid pharmacology, targeted radiopharmaceuticals, gut-brain interactions, and endothelial dysfunction. Together, these publications indicate a research portfolio connecting molecular mechanisms with therapeutic and translational questions. The bibliometric information supplied for the profile records 20 documents, 70 citations, and an h-index of 4.
Keywords
Vikrant Verma; Research Excellence Award; Biology and Life Sciences; pharmacology; bioactive compounds; Alzheimer’s disease; molecular targets; radiopharmaceuticals; gut-brain axis; cardiovascular research.
Introduction
The supplied publication record demonstrates an interdisciplinary orientation within biomedical and life-science research. Recent work includes mechanistic reviews of traditional Chinese medicine-derived compounds and Mitragyna speciosa alkaloids, as well as research concerning PSMA-targeted radiopharmaceuticals and quercetin-mediated gut-brain interactions. These subjects involve molecular pharmacology, therapeutic development, safety considerations, and translational science.
Research Profile
The reported Scopus profile identifies 20 documents, 70 citations, and an h-index of 4. These metrics provide a quantitative snapshot of indexed scholarly output and citation activity and should be interpreted in relation to field, publication age, document type, and database coverage. [1]
Research Contributions
- Analysis of molecular targets, standardization, and translational considerations for TCM-derived bioactive compounds in Alzheimer’s disease.
- Examination of structure-activity relationships and safety profiles associated with Mitragyna speciosa alkaloids.
- Review of PSMA-targeted radiopharmaceutical design and clinical translation.
- Investigation of quercetin, microbiome modulation, and neuroprotective mechanisms involving the gut-brain axis.
- Assessment of therapeutic strategies addressing endothelial dysfunction across cardiovascular and systemic diseases.
Publications
Selected publications supplied for this profile include the 2026 article on TCM-derived bioactive compounds in Pharmacological Research – Modern Chinese Medicine, the study of Mitragyna speciosa alkaloids in Current Bioactive Compounds, and work on PSMA-targeted radiopharmaceuticals in Current Radiopharmaceuticals. Additional publications address quercetin and the gut-brain axis and therapeutic strategies for endothelial dysfunction. [2] [3] [4]
Research Impact
The reported citation count and h-index document measurable scholarly visibility in indexed literature. The subject diversity of the selected publications also illustrates engagement with several areas of biomedical research, including neurodegeneration, natural-product pharmacology, molecular imaging, and vascular biology. Citation metrics are dynamic and may change as databases are updated. [1]
Award Suitability
The supplied record provides several documented elements relevant to an academic recognition profile: indexed publications, citation activity, an h-index, and recent research addressing contemporary questions in Biology and Life Sciences. The combination of mechanistic pharmacology, therapeutic investigation, and translational biomedical themes provides a substantive basis for consideration under a research-excellence framework, subject to the award’s formal evaluation criteria and verification procedures.
Conclusion
Vikrant Verma’s supplied academic profile reflects research activity in Biology and Life Sciences with publications covering molecular pharmacology and several translational biomedical themes. The reported Scopus metrics and selected 2026 publications provide measurable and recent indicators of scholarly activity. Continued publication, citation development, and interdisciplinary research may further document the evolution of this research profile.
External Links
References
- Elsevier. (n.d.). Scopus author details: Vikrant Verma, Author ID 57213651680. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=57213651680
- Verma, V. (2026). Mechanistic pharmacology of TCM-derived bioactive compounds in Alzheimer’s disease: molecular targets, standardization, and translational insights. Pharmacological Research – Modern Chinese Medicine. DOI: 10.1016/j.prmcm.2026.100831
- Verma, V. (2026). Mechanistic Insights, Structure-activity Relationships, and Safety Profile of Mitragyna speciosa Alkaloids. Current Bioactive Compounds. DOI: 10.2174/0115734072492003260811045218
- Verma, V. (2026). Theranostic applications of PSMA-targeted radiopharmaceuticals: From molecular design to clinical translation and emerging paradigms. Current Radiopharmaceuticals. DOI: 10.1016/j.craph.2026.100054
- Verma, V. (2026). Quercetin and the gut-brain axis: Microbiome modulation, neuroprotection, and therapeutic implications. AIMS Molecular Science. DOI: 10.3934/molsci.2026012
- Verma, V. (2026). Therapeutic Strategies for Endothelial Dysfunction in Cardiovascular Disease, Rheumatoid Arthritis, and Diabetes: Current and Emerging Approaches. Cardiovascular & Hematological Agents in Medicinal Chemistry. DOI: 10.2174/0118715257414596251206101856